Table 1.

Frequency of entries classified by body system treated from SAVSNET database for all valid entries (n = 1148) for cefovecin/Convenia use

Body system treated	n (%)
Skin	553 (48.2)
Urinary	157 (13.7)
Respiratory	112 (9.8)
Unclassified*	103 (9.0)
Oral including dental	101 (8.8)
Musculoskeletal	41 (3.6)
Multiple †	28 (2.4)
Gastrointestinal including liver and pancreas	27 (2.4)
Ocular	19 (1.7)
Neurological	5 (0.4)
Cardiovascular	2 (0.2)

^*Used if unclear which primary body system was being treated with Convenia, owing to lack of information in clinical notes

^†Used if more than one body system was described and it was unclear which primary body system was being treated with Convenia

SAVSNET = Small Animal Veterinary Surveillance Network